Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Morgan Stanley Bank $2 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Vinci Partners $100 million placement and strategic partnership with Ares
We advised Vinci Partners on the private placement
Semtech $250 million convertible senior notes offering
We advised Semtech on its private placement of 4% convertible senior notes due 2028
Aligos Therapeutics $92 million private placement
The PIPE included common stock and warrants
J.M. Smucker $3.5 billion notes offering
The investment-grade debt offering comprises four tranches of notes
RTX $10 billion accelerated share repurchase
The company is repurchasing shares of stock
indie Semiconductor warrant exchange offer
A total of 24,658,461 warrants were tendered for stock
Oesterreichische Kontrollbank $1 billion notes offering
The 5% notes are due 2026